CFO departure
Adial Pharmaceuticals, Inc. discloses CFO departure: Vinay Shah
Adial Pharmaceuticals, Inc. reported in a Form 8-K filed August 13, 2026 a change involving its Chief Financial Officer, Vinay Shah. The filing's own words are quoted below.
In the filing's words
the Company anticipates that the employment of its current Chief Financial Officer, Vinay Shah, will be terminated effective promptly after the 2026 Annual Meeting if Stockholder Approval is obtained, and that a new Chief Financial Officer will be appointed.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | Adial Pharmaceuticals, Inc. (ADIL) |
|---|---|
| Event | Departure |
| Outgoing | Vinay Shah |
| Effective | not stated in the source |
| 8-K filed | August 13, 2026 |
| SEC CIK | 0001513525 |
Adial Pharmaceuticals, Inc. reported this change in a Form 8-K, Item 5.02, filed August 13, 2026. The filing's own words are quoted above.
Other records naming Vinay Shah
1The outgoing officer on this record, matched by name. Career line.
2026-03-05 · 10-K signature
Vinay Shah signed Adial Pharmaceuticals, Inc.'s annual report as Chief Financial Officer (Principal Financial and Accounting Officer)
Same industry, August 2026
4Other moves filed that month at companies the roster files under SIC “Pharmaceutical Preparations”.
2 months ago· 2026-08-19DeparturePDSB
PDS Biotechnology Corporation discloses CFO departure: Lars Boesgaard
3 months ago· 2026-08-13AppointmentOLMA
Olema Pharmaceuticals, Inc. appoints Jason O'Byrne as CFO
3 months ago· 2026-08-06AppointmentNATR
Nature's Sunshine Products, Inc. appoints Ruth Perkins as CFO
3 months ago· 2026-08-03AppointmentCUE
Cue Biopharma, Inc. appoints James Ahlers as CFO
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Documented unknowns
- effective: The filing gives "promptly after the 2026 Annual Meeting", which is not a calendar date.
Something wrong about Vinay Shah? Send a correction with the primary source.